Verastem | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (39)

Latest Posts

About This Stock More About This Stock
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
Article By: ChinaBio® Today
Saturday, September 2, 2023 1:59 PM EDT
Shanghai GenFleet Technologies partnered three preclinical small-molecule candidates for RAS pathway-driven cancers to Verastem Oncology in a deal that could be worth up to $625.5 million. GenFleet will receive an initial payment of $11.5 million.
In this article: VSTM Also: BNTX, IMAB
Where Is VSTM Headed?
Article By: Zion Miller
Tuesday, January 22, 2019 11:17 PM EDT
With the recent bashing of the market as a whole and slaughter of small caps, VSTM continues to touch what some claim to be unfathomable levels.
In this article: VSTM Also: GILD, BMY, JNJ, MRK, NVS, RHHBY
Verastem, De Risked?
Article By: Zion Miller
Monday, December 31, 2018 4:11 PM EDT
VSTM has been pushed down for several reasons and was further damaged with the recent unfortunate bearish markets.
In this article: VSTM
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By: ChinaBio® Today
Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.
In this article: A, VSTM, NVS, CBMG, TTPH
3 ‘Strong Buy’ Stocks With Big Catalysts Ahead
Article By: TipRanks
Wednesday, March 14, 2018 2:21 PM EDT
Which are three of the market’s hottest stocks right now?
In this article: VSTM, AQXP, SBBP

Latest Tweets for $VSTM

No tweets yet!